The human genome project and breast cancer

Women's Health Issues

Volumn 7, Issue 4, 1997, Pages 209-214

  Olopade, Olufunmilayo I ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER SUSCEPTIBILITY; FEMALE; GENE ISOLATION; HUMAN; LIFESTYLE; MEDICAL GENETICS;

BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMAN GENOME PROJECT; HUMANS; RISK FACTORS;

EID: 0030763393     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1049-3867(97)00015-7     Document Type: Article

References (36)

1. American Cancer Society: Facts & figures. Atlanta: American Cancer Society, 1995.
2. Muir C, Waterhouse J, Mack T, Powell J, Whelan S. Cancer incidence in five continents. Vol 5. Lyon: International Agency for Research on Cancer, 1987.
3. National Center for Health Statistics. Vital statistics of the United States, vol 2, mortality. Part A. Washington (DC): U.S. Department of Health and Human Services, 1990, Pub. No. PHS 1987;90-1101.
4. Kelsey JL, Gammon MD. The epidemiology of breast cancer. CA Cancer J Clin 1991;41:147-65.
5. Miller AB, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and relevance of early detection: an update. CA Cancer J Clin 1993;43:27-41.
6. Marshall E. Search for a killer: focus shifts from fat to hormones in special report on breast cancer, 1993. Science 1993;215:618-21.
7. Hans JR, Lippman ME, Verones U. Breast cancer (Part 1). N Engl J Med 1992;327: 319-28.
8. National Cancer Institute. Cancer statistics review 1973-1989. Bethesda (MD): Public Heath Service, National Cancer Institute, 1992.
9. National Cancer Institute. NCI Announces Improvements in Breast Cancer Death Rates. May, 1996.
10. King M-C. Breast cancer genes: how many, where and who are they? Nat Genet 1992;2:125.
11. Caskey CT. Presymptomatic diagnosis: a first step toward genetic health care. Science 1992;262:48-9.
12. Hurley SF, Kaldor JM. The benefits and risk of mammographic screening for breast cancer. Epidemiol Rev 1992;14:101-30.
13. Miller AB, Baines CJ, To T, et al. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women 50-59 years. Can Med Assoc J 1992;147:1477-88.
14. Strax P. Detection of breast cancer, 1992. Cancer 1992;66:1336-40.
15. Skolnick MH, Cannon-Albright LA. Genetic predisposition to breast cancer: cancer 1992;070(Suppl):1747-53.
16. Claus EB, Risch NJ, Thompson WD. Age at onset as an indication of familial risk of breast cancer. Am J Epidemiol 1990;131:967-72.
17. Hall JM, Lee MK, Morrow J, et al. Linkage of early onset breast cancer to chromosome 17q21. Science 1990;250:1684-9.
18. Easton DF, Bishop DT, Ford D, Crockford GP, The Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993;52:687-701.
19. Miki Y, Swensen J, Shattuck-Edens D, et al. A strong candidate for the 17q-linked breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
20. Shattuck-Edens D, McClure M, Simard J, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA 1995;273:535-41.
21. Wooster R, Neuhausen S, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-90.
22. Stratton MR, Wooster R, et al. Identification of the breast cancer susceptibility gene BRCA2 Nature 1995;378.
23. Hoskins KF, Stopfer JE, Calzone KA, et al. Assessment and counseling for women with a family history of breast cancer: a guide for clinicians. JAMA 1995;273:577-85.
24. Collins FS. BRCA1 - lots of mutations, lots of dilemmas. N Engl J Med 1996;334: 186-8.
25. Fitzgerald MG, MacDonald DJ, Krainer M, et al. Germline BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 1996;334:143-9.
26. Streuwing JB, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995;11:198-200.
27. Biesecker BB, Boehnke M, Calzone K, et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 1993;269:1970.
28. Easton D, Ford D, Bishop T, The Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995;56: 265-71.
29. Tavtigran SV, Simard J, Rommers J, Couch F, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996;12:333-7.
30. Holtzman N. Are we ready to screen for inherited susceptibility to cancer? Oncology 1996;10:57-64.
31. Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG, editors. Assessing genetic risks: implications for health and social policy. Committee on Assessing Genetic Risks, Division of Health Sciences Policy, Institute of Medicine. Washington (DC): National Academy Press, 1994;1-28.
32. American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol 1996;14: 1730-6.
33. Lerman C, Narod S, Schulman, K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA 1996;275:1885-92.
34. Garber JE, Schrag D. Testing for inherited cancer susceptibility. JAMA 1996;275: 1928-9.
35. Lerman L. Psychological issues in genetic testing for breast cancer susceptibility. Ann Int Med 1994;154:609-16.
36. King MC, Rowell S, Love SM. Inherited breast and ovarian cancer: what are the risks? what are the choices. JAMA 1993;269:1975.